课题基金 / 基金详情

Tcell activation requirement in autoimmune demyelination

Tcell activation requirement in autoimmune demyelination
自身免疫性脱髓鞘中 T 细胞激活的要求
批准号:
6575793
负责人:
MICHAEL K RACKE
金额:
$33.35万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 2006-11-30

项目摘要

项目成果

MICHAEL K RACKE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):多发性硬化症(MS)是一种病因不明的中枢神经系统(CNS)炎症性脱髓鞘疾病。多发性硬化的一种可能病因是多发性硬化是一种自身免疫性疾病,其中T细胞靶向髓鞘抗原。MS是否真的是一种自身免疫性疾病仍然存在争议。许多研究人员继续寻找病原体,这可能是这种疾病发展的触发因素。我们之前对RRMS患者的研究表明,MS患者的髓磷脂反应性T细胞可以通过缺乏对共刺激激活的依赖来与健康个体的髓磷脂反应性T细胞区分开来。在先前工作的基础上,我们将测试这些髓磷脂反应性T细胞的共刺激需求在疾病过程中发生变化的假设。特别是,我们非常感兴趣的是确定CD28-共刺激非依赖性T细胞是否作为ms期间发生的慢性炎症反应的结果而出现。我们非常感兴趣的是确定髓磷脂反应性T细胞是否随着时间的推移发展出与免疫衰老一致的表型。此外,基于我们之前在实验性自身免疫性脑脊髓炎(EAE)模型中检查程序性细胞死亡的工作,我们将确定这些不依赖共刺激的CD28- T细胞是否更能抵抗细胞凋亡。我们还将研究CTLA-4分子的多态性是否在MS患者的T细胞反应调节中发挥作用。许多在MS患者中提出的研究也将在小鼠EAE系统中建模。这些研究的结果将增强我们对慢性抗原刺激的理解,比如那些被怀疑发生在MS中的,是如何改变免疫反应的。了解慢性炎症如何改变多发性硬化症患者的髓磷脂反应性T细胞,可能对各种基于免疫的治疗方法及其在治疗多发性硬化症患者中的应用时机具有广泛的意义。
英文摘要
DESCRIPTION (provided by applicant): Multiple Sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS) of unknown etiology. One possibility for the etiology of MS is that MS is an autoimmune disease, where T cells target myelin antigens. Whether MS is truly an autoimmune disease is still controversial. Many investigators continue to search for pathogens, which may be the trigger for the development of this disease. Our prior work in patients with RRMS has suggested that myelin reactive T cells in MS patients can be distinguished from those in healthy individuals by a lack of dependence upon costimulation for activation. Building on this prior work, we will test the hypothesis that the costimulatory requirements of these myelin-reactive T cells change over the course of disease. In particular, we are very interested in determining whether CD28-, costimulation-independent T cells arise as a result of the chronic inflammatory response that takes place during MS. We are very interested in determining whether myelin-reactive T cells develop a phenotype consistent with immunosenescence over time. In addition, building on our prior work examining programmed cell death in the experimental autoimmune encephalomyelitis (EAE) model, we will determine whether these costimulation-independent, CD28- T cells are more resistant to apoptosis. We will also examine whether polymorphisms in the CTLA-4 molecule can play a role in regulation of the T cell response in MS patients. Many of the proposed studies in MS patients will also be modeled in a murine EAE system. The results of these studies will enhance our understanding of how chronic antigenic stimulation, such as that which is suspected to occur in MS, modifies the immune response. Understanding how chronic inflammatory conditions modify myelin reactive T cells in MS patients may have broad implications for a variety of immunologically based therapies and the timing of their use in treating patients with MS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ninth International Congress of Neuroimmunology
  • 批准号:
    7614128
  • 项目类别:
  • 资助金额:
    $2.5万
  • 财政年份:
    2008
  • 负责人:
    MICHAEL K RACKE
  • 依托单位:
CLINICAL TRIAL: BETASERON/BETAFERON IN MS
  • 批准号:
    7718677
  • 项目类别:
  • 资助金额:
    $0.17万
  • 财政年份:
    2007
  • 负责人:
    MICHAEL K RACKE
  • 依托单位:
Immunopathogenesis of Multiple Sclerosis
  • 批准号:
    6748111
  • 项目类别:
  • 资助金额:
    $12.04万
  • 财政年份:
    2003
  • 负责人:
    MICHAEL K RACKE
  • 依托单位:
Immunopathogenesis of Multiple Sclerosis
  • 批准号:
    7497835
  • 项目类别:
  • 资助金额:
    $10.87万
  • 财政年份:
    2003
  • 负责人:
    MICHAEL K RACKE
  • 依托单位:
海外基金